116-Patient Chronic Osteomyelitis Study

In a newly published study, BonAlive® granules is confirmed to be an effective bacterial growth inhibiting and bone regenerating technology in the treatment of chronic osteomyelitis - without local antibiotics. This is the largest reported patient series in the history of use of BonAlive® granules in the treatment of chronic osteomyelitis.

Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study

Lindfors N, Geurts J, Drago L, Arts JJ, Juutilainen V, Hyvönen P, Suda A, Domenico A, Artiaco S, Alizadeh C, Brychcy A, Bialecki J, Romano C. Advances in Microbiology, Infectious Diseases and Public Health 2017.


osteomyelitis 116 patients study

 Official indication for BonAlive® granules:

    • Bone cavity filling
    • Bone cavity filling in the treatment of chronic osteomyelitis